Christopher Cutie, MD, Urology, Boston, MA, Massachusetts General Hospital

ChristopherJohnCutieMDMBA

Urology Boston, MA

Surgical Oncology

Chief Medical Officer at TARIS

Dr. Cutie is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cutie's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Urology, 2005 - 2008
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, General Surgery, 2003 - 2005
  • Yale University School of Medicine
    Yale University School of MedicineClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2021
  • American Board of Urology Urology

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • TARIS Initiates Clinical Trial of TAR-200 in Combination with Opdivo® (Nivolumab) for Patients with Muscle-Invasive Bladder Cancer
    TARIS Initiates Clinical Trial of TAR-200 in Combination with Opdivo® (Nivolumab) for Patients with Muscle-Invasive Bladder CancerJuly 11th, 2019
  • Initiates Dosing of TAR-200 (GemRIS™) in Muscle-Invasive Bladder Cancer Patients Unfit for Curative Intent Therapy
    Initiates Dosing of TAR-200 (GemRIS™) in Muscle-Invasive Bladder Cancer Patients Unfit for Curative Intent TherapyMarch 14th, 2018
  • Announces Research Collaboration Focused on Natural History of Muscle Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy
    Announces Research Collaboration Focused on Natural History of Muscle Invasive Bladder Cancer Patients Not Receiving Curative Intent TherapyMarch 14th, 2018
  • Join now to see all

Other Languages

  • German

Hospital Affiliations